K E Ranaghan
Overview
Explore the profile of K E Ranaghan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
1
Citations
32
Followers
0
Related Specialty
Related Specialty
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Callegari D, Ranaghan K, Woods C, Minari R, Tiseo M, Mor M, et al.
Chem Sci
. 2018 May;
9(10):2740-2749.
PMID: 29732058
Osimertinib is a third-generation inhibitor approved for the treatment of non-small cell lung cancer. It overcomes resistance to first-generation inhibitors by incorporating an acrylamide group which alkylates Cys797 of EGFR...